CTOs on the Move

Lasergen

www.lasergen.com

 
Lasergen is an emerging biotechnology company focused on commercializing novel technologies for DNA sequencing. Our expertise in nucleotide chemistry and next-generation sequencing has led to a number of key discoveries resulting in both game-changing sequencing chemistry (Lightning Terminators™) and a more accurate sequencing platform. While focusing on the development of current cutting-edge technology, our continued drive for innovation and extensive sequencing knowledge allows us to rapidly evolve and keep pace with fast-changing advances in the sequencing industry.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Lasergen raised $80M on 03/07/2016

Similar Companies

Chain Drug Consortium

Chain Drug Consortium is a Boca Raton, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biosense Webster

Biosense Webster is offering you exposure to the best-in-class AF* practices through our Centers of Excellence program. Our Centers of Excellence provide you with the opportunity to fine tune your approach to PAF ablation by observing cases at

U.M.G.

U.M.G. is a Harrison, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cadwell Laboratories

Cadwell is a leading manufacturer and marketer of diagnostic and monitoring products for the world of neurophysiology. We have been proudly serving you since 1979. Visit our online store for all your Electrodes and Accessories needs (US Customers

Fortimedix Surgical

Fortimedix Surgical is a fast growing medical device company with the ambition to inspire a new wave of technological advancement in the field of minimally invasive surgery. The company is headquartered in Nuth, The Netherlands, and has a US subsidiary in San Diego, CA. With a strong history as a global market leader in contract stent manufacturing, Fortimedix has been a trusted partner in the medical device industry for over 15 years. Building on our established position as a stent industry leader with state-of-the-art manufacturing capabilities, we have in-house control over the manufacturing of key components of our products, including the symphonX™ Surgical Platform. Thanks to our network within the medical device industry, we are able to work with various professional service providers for the supply of other platform components and services. This allows us to outsource cost by leveraging their expertise and infrastructure.